Trifecta Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Trifecta Capital Advisors, LLC
- $506 Billion
- Q4 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 245 shares of XBI stock, worth $21,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245
Previous 245
-0.0%
Holding current value
$21,388
Previous $24.2 Million
8.84%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
917Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$974 Million0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$888 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$834 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$744 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$699 Million0.06% of portfolio